IHC-plus(tm) CPT1A Antibody (aa621-634)
LS-B3015
ApplicationsWestern Blot, ELISA, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman
TargetCPT1A
Overview
- SupplierLifeSpan BioSciences
- Product NameIHC-plus(tm) CPT1A Antibody (aa621-634)
- Delivery Days Customer23
- Application Supplier NoteImmunohistochemistry: LS-B3015 was validated for use in immunohistochemistry on a panel of 21 formalin-fixed, paraffin-embedded (FFPE) human tissues after heat induced antigen retrieval in pH 6.0 citrate buffer. After incubation with the primary antibody, slides were incubated with biotinylated secondary antibody, followed by alkaline phosphatase-streptavidin and chromogen. The stained slides were evaluated by a pathologist to confirm staining specificity. The optimal working concentration for LS-B3015 was determined to be 4 ug/ml.. IHC, IHC-P (4 µg/ml), Peptide-ELISA (1:128000), WB (0.1 - 0.3 µg/ml) Immunohistochemistry: LS-B3015 was validated for use in immunohistochemistry on a panel of 21 formalin-fixed, paraffin-embedded (FFPE) human tissues after heat induced antigen retrieval in pH 6.0 citrate buffer. After incubation with the primary antibody, slides were incubated with biotinylated secondary antibody, followed by alkaline phosphatase-streptavidin and chromogen. The stained slides were evaluated by a pathologist to confirm staining specificity. The optimal working concentration for LS-B3015 was determined to be 4 ug/ml.
- ApplicationsWestern Blot, ELISA, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration0.5 mg/ml
- ConjugateUnconjugated
- Gene ID1374
- Target nameCPT1A
- Target descriptioncarnitine palmitoyltransferase 1A
- Target synonymsCPT I, CPT1, CPT1-L, CPTI-L, L-CPT1, carnitine O-palmitoyltransferase 1, liver isoform, carnitine palmitoyltransferase 1A (liver), carnitine palmitoyltransferase I, liver, succinyltransferase CPT1A
- HostGoat
- ReactivityHuman
- Storage Instruction-20°C
- UNSPSC41116161






